Quelle Surprise: Reuters reports Roche approached Pacific Biosciences about a takeover

Reuters has picked up on another one of my Tip TV stories.

Yesterday, the news agency "broke" the story that Swiss pharma giant Roche had approached Pacific Biosciences about a takeover deal. Here is the link:

Burmese Business - part 4

It still never ceases to amaze me how quickly stocks fall in and out of fashion with investors, traders and market participants.

Indeed, the healthcare/ biotech sector has taken another serious pasting today following worse-than-expected figures from Roche, the Swiss pharmaceutical giant. So, AstraZeneca is down 3pc today while Shire has fallen almost 5pc.

Roche back in the market for deals, according to dealReporter; no comment re BioMarin and PTC Therapeutics

Avid followers of the dealmaking frenzy in the pharmaceutical sector might want to take a look at piece on Roche Holding published a few days ago by dealReporter.

The "intelligence" service got some good quotes from Roche chief financial officer Alan Hippe, who told dealReporter that the Swiss pharmaceutical giant is still/back in the market for acquisitions in areas that don't overlap with existing drug development plans/pipelines.

RARE alert: Shire said to be weighing "transformational" $65 billion merger with BioMarin Pharmaceutical

Perhaps I spoke (or wrote) to soon about Shire's next "transformational" deal taking a while to happen - see the link: http://betaville123.blogspot.co.uk/2015/03/rare-alert-shires-next-deal-likely-to.html.

Top sources (and I mean top) tell me FTSE 100-listed Shire has set it sights on combining with BioMarin Pharmaceutical, a US-listed company that specialises in making therapies for people with extremely rare genetic diseases.

Fancy that - Roche agrees to buy InterMune for $8.3 billion

Good evening Betavillers!

I would have posted yesterday but I was taking a day off, enjoying the Notting Hill Carnival (for international readers unfamiliar with the Notting Hill Carnival, it is one of the biggest street parties in Europe held in the area of London where I live).

Fancy that - Europe's biggest drug makers said to bid for InterMune

Oh look, I see Bloomberg and Reuters are both reporting that InterMune has attracted several suitors, including GlaxoSmithKline, Actelion, Roche and Sanofi:

http://www.bloomberg.com/news/2014-08-13/europe-s-biggest-drugmakers-said-to-bid-for-intermune.html